BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 34684258)

  • 1. Bacterial Antibiotic Resistance: The Most Critical Pathogens.
    Mancuso G; Midiri A; Gerace E; Biondo C
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of medicinal plants against ESKAPE: An update.
    Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
    Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Phenotypic Antimicrobial Resistance among ESKAPE Bacteria and Enterobacterales Strains in Wild Birds.
    Russo TP; Minichino A; Gargiulo A; Varriale L; Borrelli L; Pace A; Santaniello A; Pompameo M; Fioretti A; Dipineto L
    Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoconjugate vaccines against antimicrobial resistant pathogens.
    Sorieul C; Dolce M; Romano MR; Codée J; Adamo R
    Expert Rev Vaccines; 2023; 22(1):1055-1078. PubMed ID: 37902243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
    Santajit S; Indrawattana N
    Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
    Chang RYK; Nang SC; Chan HK; Li J
    Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance trends of ESKAPE pathogens in Kwazulu-Natal, South Africa: A five-year retrospective analysis.
    Ramsamy Y; Essack SY; Sartorius B; Patel M; Mlisana KP
    Afr J Lab Med; 2018; 7(2):887. PubMed ID: 30568908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.
    Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
    Yu Z; Tang J; Khare T; Kumar V
    Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).
    Muntean MM; Muntean AA; Preda M; Manolescu LSC; Dragomirescu C; Popa MI; Popa GL
    Exp Ther Med; 2022 Aug; 24(2):508. PubMed ID: 35837033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.
    Gupta SS; Hamza Kh M; Sones CL; Zhang X; Sivaraman GK
    Funct Integr Genomics; 2024 May; 24(3):110. PubMed ID: 38806846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary.
    Orosz L; Lengyel G; Ánosi N; Lakatos L; Burián K
    Acta Microbiol Immunol Hung; 2022 Jan; ():. PubMed ID: 35084364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.